Polycystic ovarian syndrome (PCOS) is a prevailing endocrine and metabolic disorder
occurring in about 6–20% of females in reproductive age. Most symptoms of PCOS arise …

Polycystic ovary syndrome (PCOS) is one of the most common endocrine and metabolic
disorders in premenopausal women. Heterogeneous by nature, PCOS is defined by a …

Polycystic ovary syndrome (PCOS) is a complex and heterogeneous endocrine disease
characterized by clinical or laboratorial hyperandrogenism, oligo-anovulation and metabolic …

Polycystic ovary syndrome (PCOS) is a common infertility disorder affecting a significant
proportion of the global population. It is the main cause of anovulatory infertility in women …

Polycystic ovary syndrome (PCOS) was hypothesized to result from functional ovarian
hyperandrogenism (FOH) due to dysregulation of androgen secretion in 1989–1995 …

Polycystic ovary syndrome (PCOS) is now recognized as an important metabolic as well as
reproductive disorder conferring substantially increased risk for type 2 diabetes. Affected …

In female mammals, mechanisms have been developed, throughout evolution, to integrate
environmental, nutritional and hormonal cues in order to guarantee reproduction in …

Polycystic ovary syndrome (PCOS) is a very common endocrine disorder characterized by
chronic anovulation, clinical and/or biochemical hyperandrogenism, and/or polycystic …

Insulin has complex effects on cell growth, metabolism and differentiation, and these effects
are mediated by a cell-surface bound receptor and eventually a cascade of intracellular …

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder in reproductive-aged
women. Clinical manifestations include hyperandrogenism, chronic anovulation, polycystic …